Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion

Feb 20, 10:30 AM

Headliner
Share
Subscribe
In today’s Pharma Pulse, Johnson & Johnson commits over $1 billion to a new biomanufacturing site in Pennsylvania, while Hims & Hers enters a $1.15 billion agreement to acquire Australian telehealth leader Eucalyptus.
Share
Subscribe
Next
Pharma Pulse: mRNA Legal Wars and the Community Pharmacy Shield
Top episodes
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce